ArticleUpdates in surgery2026
Quality of life, postoperative outcomes and hernia recurrence following laparoscopic intracorporeal rectus aponeuroplasty (LIRA) for incisional and primary ventral hernia repair.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to evaluate the quality of life (QoL), early post-operative complications, and hernia recurrence rate following Laparoscopic Intracorporeal Rectus Aponeuroplasty (LIRA) for incisional and primary ventral hernia repair. A prospective cohort study of patients operated for primary or incisional hernia of midline by Laparoscopic Intracorporeal Rectus Aponeuroplasty (LIRA) was performed. The study was conducted from September 2023 to May 2024 to evaluate the LIRA technique performed on patients with ventral hernias type M2-M3, W2. The data analyzed included patient demographics, operative parameters, pain, outcomes, bulging, seroma and recurrence rates and quality of life (QoL). A computerized tomography was performed preoperatively and at the sixth postoperative month to evaluate recurrence. QoL was assessed using the EuraHS-QoL scale preoperatively and at the first and sixth months after the surgery. Thirty-eight patients were included. Mean width of the defect was 4.96 cm. Average visual analogue scale of pain (VAS) was 10.06 ± 6.17 at the preoperative time, 6.68 ± 1.83 at the first day, 2.66 ± 1.26 at the seventh day and 0.75 ± 2.55 at the thirtieth postoperative day. Pre-operative and post-operative EuraHS-QoL questionnaire scores were available for 97.4% of the patients enrolled and showed significant improvement in pain (10.06 vs. 0.75, p < 0.001), restrictions (average 13.2 vs. 0.69, p < 0.001) and cosmetic appearance (10.36 vs. 1.64, p < 0.001). The recurrence rate was 2.7%. The mean follow-up was 6 months. So far, this is the first prospective cohort study that evaluates the impact of LIRA technique on patient´s quality of life with primary ventral hernia (PVH) or incisional ventral hernia (IVH) types M2-M3, W2. Our results show significant improvement in all parameters of the EuraHS-QOL scores (pain, activity, and cosmetic discomfort) for patients undergoing LIRA, with an acceptable postoperative outcome and hernia recurrence rate at a short-term follow-up.
Indexed as
Identifiers
42154171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.